Skip to main content
Clinical Trials/NL-OMON41502
NL-OMON41502
Completed
Phase 2

Radioembolization for Colorectal Liver Metastases after Ablation: a Prospective study - The RELAPSE study

niversitair Medisch Centrum Utrecht0 sites50 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
'Colorectal liver metastases' and 'liver cancer disseminated from the colon'
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who have signed written informed consent
  • 2\. Patients undergoing open, laparoscopic or percutaneous ablation therapy
  • 3\. Age \* 18 years
  • 4\. ECOG performance status of 0\-2
  • 5\. Subjects with at least one and a maximum of five measurable lesion according to the RECIST criteria (\>5\.0 cm in axial plane) on pre\-operative imaging
  • 6\. Normal renal and liver function tests at baseline

Exclusion Criteria

  • 1\. Irresectable extrahepatic metastases
  • 2\. Ablation procedure combined with liver resection
  • 3\. Pregnant or breast\-feeding patients
  • 4\. Any form of chemotherapy within 2 months prior to the Y\-90 radioembolization
  • 5\. Exclusion criteria of radioembolization:
  • \- Compromised main portal vein
  • \- Uncorrectable extrahepatic shunting to the gastrointestinal tract
  • \- Unacceptable shunting to the lungs

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Combination of locally administered radiotherapy and thermal tumour destruction for treatment of liver metastases originated from primary bowel cancerColorectal liver metastases, Recurrence, Radiofrequency ablation, Radioembolization
NL-OMON29581Prof. Dr. R. van HillegersbergUniversity Medical Center UtrechtDepartment of Surgery 50
Completed
Phase 1
Hepatic Resection for Colorectal Liver Metastases following Panitumumab(Vectibix) with Chemotherapy Cohort studynresectable colorectalcancer with hepatic metastases
JPRN-UMIN000017397Gastroenterological Surgery1, Hokkaido University Graduate school of medicine100
Completed
Not Applicable
Assessment of the Safety and Efficacy of Intra-Arterial Liver Isolation Chemotherapy Using an Implantable Vascular Access System1. Secondary hepatic metastases from colorectal cancer2. Hepatocellular carcinoma1. Secondary hepatic metastases from colorectal cancer2. Hepatocellular carcinomaCancer - Liver
ACTRN12611001273976Dr Rodney Lane10
Completed
Not Applicable
Surgery for colorectal liver metastases in the setting of extrahepatic disease in the era of multidisciplinary approachesExtrahepatic disease from colorectal cancer
JPRN-UMIN000029660Cancer Institute Hospital of the Japanese Foundation for Cancer Research581
Completed
Phase 2
on-resectable colorectal liver metastases treated with cetuximab induction toward liver R0 resection trial
JPRN-UMIN000007923Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo50